|
|
||||||||
2, and1 Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas 66160; and 2 Hoffmann-La Roche, Nutley, New Jersey 07110-1199
We investigated the effects of 1,25-dihydroxyvitamin
D3 [25(OH)2D3] on
tissue plasminogen activator (tPA) secretion from primary cultures of
rat heart microvascular cells. After an initial 5-day culture period,
cells were treated for 24 h with 1,25(OH)2D3
and several of its analogs. The results showed that
1,25(OH)2D3 induced tPA secretion at
10
10 to
10
16 M. A less calcemic analog,
Ro-25-8272, and an analog that binds the vitamin D receptor but is
ineffective at perturbing Ca2+ channels, Ro-24-5531,
were ~10% as active as 1,25(OH)2D3. An analog that binds the vitamin D receptor poorly but is an effective Ca2+ channel agonist, Ro-24-2287, required
~10
13 M to induce tPA secretion.
Combinations of Ro-24-5531 and Ro-24-2287 were approximately
as potent as 1,25(OH)2D3. Treatment of the cells with BAY K 8644 or thapsigargin also increased tPA secretion, suggesting that increased cytosolic calcium concentration
([Ca2+]) induces tPA secretion. The results
suggested that the sensitivity of the tPA secretory response of
microvascular cells to 1,25(OH)2D3 was
due in part to generation of a vitamin D-depleted state in vitro and in
part to synergistic effects of 1,25(OH)2D3 on
two different induction pathways of tPA release.
heart; vitamin D; calcium; analogs
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |